DE602004025344D1 - Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon - Google Patents

Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon

Info

Publication number
DE602004025344D1
DE602004025344D1 DE602004025344T DE602004025344T DE602004025344D1 DE 602004025344 D1 DE602004025344 D1 DE 602004025344D1 DE 602004025344 T DE602004025344 T DE 602004025344T DE 602004025344 T DE602004025344 T DE 602004025344T DE 602004025344 D1 DE602004025344 D1 DE 602004025344D1
Authority
DE
Germany
Prior art keywords
preparation
polymermicelles
manufacturing
biodegradable branched
branched polylactide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004025344T
Other languages
English (en)
Inventor
Min-Hyo Seo
Bong-Oh Kim
In-Ja Choi
Myung-Seob Shim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Biopharmaceuticals Corp
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Publication of DE602004025344D1 publication Critical patent/DE602004025344D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004025344T 2003-12-04 2004-12-03 Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon Active DE602004025344D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020030087459A KR20050054129A (ko) 2003-12-04 2003-12-04 고분자 미셀을 형성하는 생분해성 분지형 폴리락트산유도체, 및 그의 제조방법 및 용도
PCT/KR2004/003174 WO2005054333A1 (en) 2003-12-04 2004-12-03 Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use

Publications (1)

Publication Number Publication Date
DE602004025344D1 true DE602004025344D1 (de) 2010-03-18

Family

ID=36642449

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025344T Active DE602004025344D1 (de) 2003-12-04 2004-12-03 Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon

Country Status (13)

Country Link
US (1) US8021652B2 (de)
EP (1) EP1633797B1 (de)
JP (2) JP2006526053A (de)
KR (2) KR20050054129A (de)
CN (1) CN100386358C (de)
AT (1) ATE456600T1 (de)
AU (1) AU2004295264B2 (de)
CA (1) CA2523989C (de)
DE (1) DE602004025344D1 (de)
HK (1) HK1089459A1 (de)
MX (1) MXPA05011584A (de)
NZ (1) NZ543001A (de)
WO (1) WO2005054333A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005505675A (ja) * 2001-10-18 2005-02-24 サムヤン コーポレイション 高分子ミセルを形成するｐＨ応答性生分解性ポリ乳酸誘導体及び難溶性薬物伝達体への当該誘導体の使用
EP1367080A1 (de) 2002-05-29 2003-12-03 Hycail B.V. Hyperverzweigte Polyhydroxycarbonsäurepolymere
JP2012233208A (ja) * 2005-10-03 2012-11-29 Dai Ichi Kogyo Seiyaku Co Ltd 機能性フィラーおよびそれを含有する樹脂組成物
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US8802126B2 (en) * 2008-06-30 2014-08-12 Abbott Cardiovascular Systems Inc. Polyester implantable medical device with controlled in vivo biodegradability
US8137818B2 (en) * 2008-07-28 2012-03-20 Tate & Lyle Ingredients Americas Llc Poly(lactic acid)-containing compositions for use in imparting oil, grease, or water resistance to paper
US9518149B2 (en) 2008-11-07 2016-12-13 Samyang Biopharmaceuticals Corporation Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof
EP2201935B1 (de) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren
ATE539778T1 (de) * 2009-04-23 2012-01-15 Vivoxid Oy Biokompatibler verbund und seine verwendung
FR2967416B1 (fr) * 2010-11-15 2012-12-21 Ipsen Pharma Sas Procede de preparation de polymeres a architecture variee et amorcage amide
KR101467275B1 (ko) * 2011-12-19 2014-12-02 주식회사 삼양바이오팜 분산성이 향상된 생분해성 고분자 미립자의 조성물 및 그 제조방법
WO2013124867A1 (en) 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules
FR2995901B1 (fr) * 2012-09-21 2015-08-14 Inst Corps Gras Etudes Et Rech S Tech Iterg Nouveaux pre-polymeres biosources et leurs utilisations pour la preparation de polymeres utiles comme additifs dans une matrice poly(acide lactique)
JP6164860B2 (ja) * 2013-02-15 2017-07-19 三井化学株式会社 ポリマンデル酸
WO2014141289A1 (en) 2013-03-12 2014-09-18 Amrita Vishwa Vidyapeetham University Photo - chemo composition on the basis of microcapsules with a core -shell structure
CN104292444B (zh) * 2014-10-15 2016-06-29 四川大学 具有精确可控分子结构的类流星锤型聚乳酸的合成方法
JP2023515407A (ja) * 2020-02-21 2023-04-13 ネイチャーワークス・エル・エル・シー 低分子量の非晶質グレードのポリ乳酸樹脂を含有する化粧用組成物
KR102460624B1 (ko) 2020-09-22 2022-10-28 가톨릭대학교 산학협력단 제어 약물 방출 및 x-선 이미징이 가능한 약물 전달체 및 이의 용도
CN114437319B (zh) * 2022-01-12 2023-08-15 青岛科技大学 一种利用平推流反应器快速可控制备乙交酯-丙交酯共聚物的方法
CN114773581B (zh) * 2022-04-25 2024-06-25 万华化学集团股份有限公司 一种聚乳酸组合物及其制备方法
CN115260478B (zh) * 2022-07-19 2024-02-02 绍兴文理学院 一种高强高韧性聚乳酸共聚物的制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3065384B2 (ja) * 1991-06-05 2000-07-17 旭硝子株式会社 ラクチド系重合体の製造方法
JPH06322805A (ja) * 1993-05-13 1994-11-22 Matsushita Electric Ind Co Ltd 画像認識装置付き便所
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
NZ313769A (en) 1995-08-10 2000-02-28 Kazunori Kataoka block polymer having a functional group presented on each end
KR0180334B1 (ko) 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
JP3155013B2 (ja) * 1996-04-23 2001-04-09 キナートン・リミテッド 酸性ポリ乳酸ポリマー
JPH10110019A (ja) * 1996-10-08 1998-04-28 Kazunori Kataoka 安定化高分子ミセルおよび生理活性物質のキヤリヤーとしてのその使用
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
JP4565290B2 (ja) * 1999-12-01 2010-10-20 東洋紡績株式会社 高水酸基濃度を有するオキシ酸系脂肪族ポリエステルおよびオキシ酸系脂肪族ポリエステル組成物
EP1306013A1 (de) * 2001-03-28 2003-05-02 Hycail B.V. Biologisch abbaubare Kaugummigrundmasse
KR100492805B1 (ko) 2001-10-18 2005-06-07 주식회사 삼양사 안정성이 향상된 고분자 미셀 조성물
JP2005505675A (ja) 2001-10-18 2005-02-24 サムヤン コーポレイション 高分子ミセルを形成するｐＨ応答性生分解性ポリ乳酸誘導体及び難溶性薬物伝達体への当該誘導体の使用
KR100531269B1 (ko) * 2001-12-04 2005-11-28 주식회사 삼양사 수용액에서 안정한 미셀 또는 나노 파티클을 형성하는고분자 조성물
KR100703872B1 (ko) * 2003-10-10 2007-04-09 주식회사 삼양사 양친성 블록 공중합체 및 이를 포함하는 약물 전달용고분자 조성물

Also Published As

Publication number Publication date
EP1633797A4 (de) 2009-05-13
US8021652B2 (en) 2011-09-20
WO2005054333A1 (en) 2005-06-16
HK1089459A1 (en) 2006-12-01
JP2006526053A (ja) 2006-11-16
CA2523989A1 (en) 2005-06-16
KR20050054129A (ko) 2005-06-10
NZ543001A (en) 2009-09-25
CA2523989C (en) 2009-01-27
AU2004295264A1 (en) 2005-06-16
US20070003625A1 (en) 2007-01-04
KR100724719B1 (ko) 2007-06-04
MXPA05011584A (es) 2005-12-14
JP2009263680A (ja) 2009-11-12
EP1633797B1 (de) 2010-01-27
CN1780868A (zh) 2006-05-31
EP1633797A1 (de) 2006-03-15
AU2004295264B2 (en) 2009-10-29
ATE456600T1 (de) 2010-02-15
JP5579406B2 (ja) 2014-08-27
CN100386358C (zh) 2008-05-07
KR20060009831A (ko) 2006-02-01

Similar Documents

Publication Publication Date Title
DE602004025344D1 (de) Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
DE50307267D1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60024830D1 (de) Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
DE50111753D1 (de) Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
EP2316830A3 (de) N-sulfonylierte aminosäurederivate und ihre verwendung als matriptase- inhibitoren
DE502004002037D1 (de) Umgelagerte pentanole, ein verfahren zu ihrer herstellung und ihre verwendung als entz ndungshemmer
MA27232A1 (fr) Derives d'acide n-benzoylureidocinnamique, leurs procedes de preparation et leurs utilisations
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE284405T1 (de) Neues verfahren zur herstellung von oxabispidinen
ATE442355T1 (de) Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung
DE60313184D1 (de) Verfahren zur herstellung von dendrimeren, bausteinverbindung und verfahren zur herstellung von thiophenverbindungen
ATE304018T1 (de) Phthalsäurediamide, ein verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE59709792D1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
ATE392413T1 (de) Verfahren zur herstellung von beta-alaninamiden
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen
ATE386735T1 (de) Substituierte benzoylureidopyridyl-piperidin- und pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
DE60004850D1 (de) Verfahren zur herstellung von (r) und (s)-aminocarnitin und deren derivative aus d- und l-aspargin säure
ATE372994T1 (de) Herstellung von milchsäurederivaten und ihre anwendung
DE50101634D1 (de) VERFAHREN ZUR HERSTELLUNG VON IMIDAZO [1,2-c] [2,3]BENZODIAZEPINEN UND ZWISCHENPRODUKTE BEI DEREN HERSTELLUNG
BR0208462A (pt) Processo para a preparação de derivados imidazólicos e novas estruturas cristalinas dos mesmos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1633797

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

R081 Change of applicant/patentee

Ref document number: 1633797

Country of ref document: EP

Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR

Free format text: FORMER OWNER: SAMYANG CORP., SEOUL/SOUL, KR

Effective date: 20120813

R082 Change of representative

Ref document number: 1633797

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20120813